Finally new tools are available to combat drug resistant tuberculosis, but how do we make them work? Models to determine effective implementation strategies in Australia and our region [ 1/1/2022 - 12/31/2026 ]

Research Grant

Brief description The risk of drug resistance in tuberculosis (MDR TB) is thwarting control efforts and must be addressed. Potential strategies being considered are; treating MDR TB in the latent phase, using new short-course treatment for active TB and using new vaccines. My work develops simulation models to test strategies before they are implemented, to maximise impact and avoid costly or low-impact interventions. I will examine strategies in Australia and in high burden countries in Australia’s region.

Funding Amount $1,562,250

Funding Scheme Investigator Grants

Chief Investigator Prof Emma McBryde

Notes Emerging Leadership 2